Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare OTCMKTS:ATMS OTCMKTS:GBUX NASDAQ:SHOT OTCMKTS:VAPE On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeATMSArtemis Therapeutics$0.00$0.11▼$5.00$55.79M-1.922,942 shsN/AGBUXGivBux$0.67-8.6%$1.36$0.20▼$10.05$63.55M-13.5456,990 shs32,220 shsSHOTSafety Shot$0.43+7.1%$0.57$0.23▼$1.77$62.58M1.673.67 million shs2.31 million shsVAPEVape$21.30-1.4%$16.92$5.60▼$82.88$17.91M0.77144,105 shs91,313 shsThese 7 Stocks Will Be Magnificent in 2025Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2025. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceATMSArtemis Therapeutics0.00%0.00%0.00%0.00%0.00%GBUXGivBux+1.25%-3.66%-49.66%-77.88%+43.14%SHOTSafety Shot-3.84%-15.27%-40.11%+40.03%-58.27%VAPEVape-4.51%+2.76%-47.29%+21,599,900.00%+21,599,900.00%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationATMSArtemis TherapeuticsN/AN/AN/AN/AN/AN/AN/AN/AGBUXGivBuxN/AN/AN/AN/AN/AN/AN/AN/ASHOTSafety Shot0.3191 of 5 stars0.03.00.00.02.10.80.0VAPEVapeN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceATMSArtemis Therapeutics 0.00N/AN/AN/AGBUXGivBux 0.00N/AN/AN/ASHOTSafety Shot 0.00N/AN/AN/AVAPEVape 4.00Strong BuyN/AN/ACurrent Analyst Ratings BreakdownLatest VAPE, GBUX, SHOT, and ATMS Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/25/2025VAPEVapeAtrium ResearchSubscribe to MarketBeat All Access for the recommendation accuracy ratingUpgradeStrong-Buy(Data available from 8/29/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookATMSArtemis Therapeutics$310K0.00N/AN/A($0.01) per share0.00GBUXGivBux$540K117.69N/AN/A($0.09) per share-7.44SHOTSafety Shot-$91.96K-675.84N/AN/A$0.16 per share2.68VAPEVape$3.28M5.46N/AN/AN/A∞Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateATMSArtemis Therapeutics-$1.36MN/A0.00N/AN/A-299.54%N/A-425.51%N/AGBUXGivBux-$3.32M-$0.08N/A∞N/A-1,204.21%N/A-11,083.35%N/ASHOTSafety Shot-$49.41MN/A0.00∞N/AN/A-517.46%-208.23%11/11/2025 (Estimated)VAPEVapeN/A-$4.23N/A∞N/AN/AN/AN/AN/ALatest VAPE, GBUX, SHOT, and ATMS EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/14/2025Q2 2025SHOTSafety ShotN/A-$0.03N/A$0.09N/A$0.45 million8/13/2025Q2 2025GBUXGivBuxN/A-$0.06N/A-$0.06N/A$0.06 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthATMSArtemis TherapeuticsN/AN/AN/AN/AN/AGBUXGivBuxN/AN/AN/AN/AN/ASHOTSafety ShotN/AN/AN/AN/AN/AVAPEVapeN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioATMSArtemis TherapeuticsN/A0.150.12GBUXGivBuxN/A0.010.01SHOTSafety ShotN/A1.161.11VAPEVapeN/AN/AN/ACompare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipATMSArtemis TherapeuticsN/AGBUXGivBuxN/ASHOTSafety Shot12.55%VAPEVapeN/AInsider OwnershipCompanyInsider OwnershipATMSArtemis Therapeutics7.45%GBUXGivBuxN/ASHOTSafety Shot19.13%VAPEVape4.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableATMSArtemis Therapeutics1112.03 million103.69 millionNot OptionableGBUXGivBux21294.85 millionN/ANot OptionableSHOTSafety Shot10144.87 million117.15 millionOptionableVAPEVape30841,000N/ANot OptionableVAPE, GBUX, SHOT, and ATMS HeadlinesRecent News About These Companies‘They literally see their children walking across the street to purchase these products’: Task force to regulate over 70 Henrico vape and smoke shops5 hours ago | msn.comJB vape shop says stock still available for delivery in S'pore, sale continues despite harsher penalties5 hours ago | mothership.sgM2 men charged with importing vape-related items at Woodlands Checkpoint as ICA steps up checksAugust 29 at 2:16 AM | channelnewsasia.comCSingapore's New Vape Laws: Penalties for Tourists and ForeignersAugust 29 at 2:16 AM | en.tempo.coEMyrtle Beach police target 5 vape and smoke shops suspected of selling items disguised as food and candyAugust 28 at 9:15 PM | yahoo.comMayor Arceneaux on Shreveport vape shop policy, new SPD drones, substationAugust 28 at 9:15 PM | yahoo.comABC-7 at 4: “Spot the Vape” Paso del Norte Health Foundation creates interactive game to educate the communityAugust 28 at 9:15 PM | kvia.comKThree Danbury vape shops found to be illegally selling THC, police sayAugust 28 at 9:15 PM | registercitizen.comROrangeburg County deputies searching for alleged shoplifter targeting vape shopsAugust 28 at 9:15 PM | abccolumbia.comAPolice bust syndicate selling drug-laced vapeAugust 28 at 9:15 PM | thestar.com.myTCaning and fines for those caught in Singapore drug vape crackdownAugust 28 at 4:14 PM | msn.comDesigned to deceive: A call for urgent action on vape device designAugust 28 at 4:14 PM | msn.comSingapore to increase fines, threaten caning for vape usersAugust 28 at 4:14 PM | msn.comVape and Kpod situation dealt with by authorities 'as fast as we could', says Ong Ye KungAugust 28 at 4:14 PM | channelnewsasia.comCTexas Ban on Chinese Vape Products Can Take Effect, Judge SaysAugust 28 at 4:14 PM | news.bloomberglaw.comNHanover ordinance tightens regulations around future vape shopsAugust 28 at 4:14 PM | msn.comHigher fines for vape users, caning for Kpod suppliers among harsher penalties to kick in from SeptemberAugust 28 at 4:14 PM | channelnewsasia.comCParliamentary committee urges poison labels and stronger measures for vape productsAugust 27 at 9:56 AM | thestar.com.myTTeenagers death sparks proposed Vape store regulations in ShreveportAugust 27 at 9:56 AM | msn.comBPOM to Crack Down on Vape Products Found Containing KetamineAugust 27 at 9:56 AM | en.tempo.coENew MarketBeat Followers Over TimeMedia Sentiment Over Time Top HeadlinesView All HeadlinesBuffett Makes Big Moves Outside of UNH: A Buy and Sell BreakdownBy Leo Miller | August 18, 20253 Companies That Will Profit From Trump's Semiconductor TariffsBy Jordan Chussler | August 14, 2025An Atomic Sized Surge Is Brewing for NuScale Power Stock PriceBy Thomas Hughes | August 11, 20253 Stocks Riding the AI Data Center Buildout WaveBy Chris Markoch | August 6, 20253 Earnings Reports Give a Snapshot of Consumer SentimentBy Nathan Reiff | August 13, 2025VAPE, GBUX, SHOT, and ATMS Company DescriptionsArtemis Therapeutics OTCMKTS:ATMSArtemis Therapeutics, Inc. is a biopharmaceutical company. It develops new treatments for serious and life-threatening infections. It Includes cytomegalovirus and malaria. The company was founded on April 22, 1997 and was headquartered in New York, NY.GivBux OTCMKTS:GBUX$0.67 -0.06 (-8.59%) As of 03:31 PM EasternGivBux, Inc. was founded in 2018 and is based in Newport Beach, California.Safety Shot NASDAQ:SHOT$0.43 +0.03 (+7.12%) As of 03:52 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Safety Shot, Inc., a wellness and functional beverage company, researches and develops over-the-counter products and intellectual property. The company offers Safety Shot Beverage, an over-the-counter drink that lowers blood alcohol content. It also develops Photocil to address psoriasis and vitiligo; JW-700 to treat hair loss; JW-500 for women's sexual wellness; and NoStingz, a jellyfish sting prevention sunscreen. The company sells its products through distributors, retailers, and e-commerce websites. The company was formerly known as Jupiter Wellness, Inc. and changed its name to Safety Shot, Inc. in September 2023. Safety Shot, Inc. was incorporated in 2018 and is based in Jupiter, Florida.Vape OTCMKTS:VAPE$21.30 -0.30 (-1.39%) As of 08/28/2025Vape Holdings, Inc. does not have significant operations. Previously, the company was engaged in design, marketing, and distribution of ceramic vaporization products. Vape Holdings, Inc. is based in Agoura Hills, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Ollie’s Bargain Outlet: Buy it While It’s Still a Bargain Best Buy Marketplace: Potential Growth Catalyst or Risky Gimmick? CrowdStrike at a Crossroads: AI Halo vs. Risks Snowflake’s Snowballing Business and Robust Stock Price Outlook NVIDIA's Earnings Show a Green Light for Taiwan Semiconductor NVIDIA Stock Could Pull Back in September, But Don’t Bet on It NIO Just Got Its Second Upgrade of the Month, and It’s Big Chevron Stock Outlook: Dividend Growth Meets Inflation Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access